The U.S. Food and Drug Administration’s (FDA) recent approval of Takeda‘s injection therapy Mimrylo (rusfertide) to treat excessive blood cell production in adults with…
News
Adding the experimental anti-CD38 therapy felzartamab reduced the risk of disease progression among people with hard-to-treat myeloma in a Phase 3 clinical trial conducted…
A large U.S. clinical trial is now underway to test a newly approved pancreatic cancer drug in combination with an experimental therapy in people…
For people with myeloma who undergo a stem cell transplant using their own cells, the key determinant of the treatment’s effects is the number…
GYNECOLOGICAL CANCER
Early ovarian cancer trial seeking participants to test higher therapy dose
An early-stage U.S. clinical trial testing the infusion treatment liraltagene autoleucel (lira-cel) for ovarian cancer is now seeking women whose cancer has proven hard…
A short course of ultra-low-dose radiation may relieve pain for many people with multiple myeloma who have uncomplicated bone lesions, with minimal side effects,…
New data from a long-term clinical trial show 10 of 20 people with hard-to-treat multiple myeloma are alive and free from disease progression five…
ACUTE MYELOID LEUKEMIA
FDA green lights first-in-human study of infusion leukemia treatment
The U.S. Food and Drug Administration (FDA) has given Orum Therapeutics the go-ahead to launch its first clinical trial testing ORM-1153, an experimental treatment…
An arm of the European Medicines Agency (EMA) has recommended expanding the European approval of Johnson & Johnson‘s Tecvayli (teclistamab) to treat adults with…
The experimental immunotherapy IGV-001 may improve survival outcomes in certain people with an aggressive form of glioma called glioblastoma (GBM), according to a new…
Recent Posts
- Newly approved injection therapy gives PV patients a new option
- Inventing words for caregiving experiences no else understands
- New add-on therapy may help delay worsening in hard-to-treat myeloma
- US trial testing new med in combo with approved drug for pancreatic cancer
- The power of hope against a new multiple myeloma diagnosis